First copies of gilead virus drug to start selling in Bangladesh
Thursday, 21 May, 2020, 15:45
Bangladesh’s Beximco Pharmaceuticals Ltd. said it has become the world’s first company to start selling the generic version of Gilead Sciences Inc.’s antiviral drug on mounting urgency to treat the infection caused by the deadly coronavirus across the developing world.
The Dhaka-based Beximco, which counts Norges Bank as one of its investors, will sell remdesivir for about 6,000 taka ($71) a vial to private clinics but will give it free to state-run hospitals treating Covid-19 patients, Rabbur Reza, chief operating officer at the company, said in an interview. A critically ill Covid-19 patient will need at least six vials, he said.
Biden will present his plan to fight COVID-19. He will oblige all state residents to wear masks85610.11.2020, 03:10
Andrea Wiktorin expressed readiness from the European Union to support the health care sector in Armenia37818.10.2020, 11:30
Conjoined 14-month-old twins born locked in an embrace are successfully separated in Michigan following 11-hour surgery involving more than 24 doctors and nurses (photo)36123.09.2020, 00:50
Deputy Prime Minister of Uzbekistan dies of coronavirus58620.09.2020, 17:40
UK entering second wave of coronavirus, Boris Johnson warns62019.09.2020, 13:15
Israel Shuts Schools on Thursday, a Day Ahead of National Lockdown, Angering Parents53317.09.2020, 21:30
Ministers back 5-year plan to put health in Europe on track61415.09.2020, 20:20
China coronavirus vaccine may be ready for public in November: official37315.09.2020, 15:05